02245nam a2200397 i 4500 267577 267577 on1007740358 BD 20171226122611.0 he bmb024bbca 171026s2017 dcua bb f000 0 eng c PUCPR eng rda GPO MvI pcc n-us--- BDDF KF26 .L277 2014 1043-B (MF) Y 4.L 11/4:S.HRG.113-859 Y 4.L 11/4:S.HRG.113-859 United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging, author. Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014. Washington : U.S. Government Publishing Office, 2017. iii, 65 pages : illustrations ; 24 cm. text txt rdacontent microform h rdamedia microfiche he rdacarrier S. hrg. ; 113-859 Shipping list no.: 2017-0113-M. Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. CRDP Program record. Includes bibliographical references. Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2017] 1 microfiche : negative. Generic drugs Prices United States. Prescription pricing United States. Legislative hearings. lcgft Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging. Why are some generic drugs skyrocketing in price? (DLC) 2017415497 (OCoLC)989729813 Online version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging. Why are some generic drugs skyrocketing in price? (OCoLC)988946299 United States. Congress. Senate. S. hrg. ; 113-859. sudocs 12 0 0 sudocs 0 0 7 7 5 2017-12-26 Federal Depository 0.00 0 Y 4.L 11/4:S.HRG.113-859 Y4L114SHRG113859 2017-12-26 00:00:00 2017-12-26 12